Dr. Robert Newton is a Professor and Head of the Lung Health Research Group in the Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. His research focuses on asthma, COPD, and molecular mechanisms of anti-inflammatory glucocorticoid action, particularly how they are enhanced by long-acting β2-agonists (LABAs).

Julia is a dedicated pharmacologist specialising in lung diseases, focusing on COPD and viral AECOPD, with a special interest in the cytokine Transforming Growth Factor Beta. Julia is currently a Research Fellow at Monash University, where her research aims to develop a novel mouse model of COPD to assess therapeutic strategies for viral-induced inflammation and lung damage. I utilise cutting-edge ex vivo models, including precision-cut lung slices (PCLS), to test drug efficacy and improve treatments for COPD.

Dr. Arpita Das, a promising young scientist, earned her Ph.D. in Nutrition and Health Sciences from Taipei Medical University, Taiwan (R.O.C.) in 2024. She is currently a Postdoctoral Researcher at the Center for Drug Research and Development and the Graduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Taoyuan, Taiwan (R.O.C.). Her research integrates dietary pattern analysis, nutrigenomics, genomics, and computational approaches to elucidate disease–gene interactions and complex inflammatory pathways, advancing precision nutrition and translational strategies for inflammatory diseases. Dr. Das has authored over 8 peer-reviewed publications and presented her work at international scientific conferences, reflecting her ongoing contributions to multidisciplinary research at the interface of nutrition, molecular biology, and translational health sciences.

Tiina Lehtola is a medical doctor who graduated from Medical School at Tampere University in Finland. She is currently a PhD student in medicine and her doctoral research focuses on the role of MKP-1 as an anti-inflammatory mechanism and drug target in inflammatory diseases. Tiina has had a strong interest in pharmacology since her medical studies and works in the Immunopharmacology Research Group at Tampere University, headed by Professor Eeva Moilanen. In addition to her research, she is specializing in anesthesia and critical care in her clinical career.

Aaron is a third year PhD student in the Airway Epithelial Research team at the Wal-yan Respiratory Research Centre. He is undertaking candidature with The Kids Research Institute and the School of Human Sciences at the University of Western Australia. His research focuses on therapeutic targeting of defective airway epithelial cell repair in childhood asthma. This research is crucial for validating drug safety & efficacy, and understanding therapeutic mechanism-of-action in order to ameliorate disease trajectories in asthma via early life treatment interventions.

Dr. Nurgul Ablakimova, MD, PhD, is an Assistant Professor in the Department of Pharmacology and Clinical Pharmacology at West Kazakhstan Marat Ospanov Medical University and serves as a Clinical Pharmacologist and Head of the Department of Hospital Pharmacy at the Regional Perinatal Center. Her primary research interests include antimicrobial resistance, antimicrobial stewardship, rational antibiotic therapy, and clinical pharmacology approaches in internal diseases. She is a medical doctor and a clinical pharmacologist of the 2nd qualification category with six years of combined clinical and teaching experience. Dr. Ablakimova actively contributes to intramural research projects and grant-funded studies supported by the Ministry of Science and Higher Education of Kazakhstan, helping to develop targeted educational and clinical interventions. She has authored original research articles, reviews, systematic reviews, and meta-analyses in peer-reviewed international journals and holds an h-index of 4. She is a member of the Association of Clinical Pharmacologists and Pharmacists of Kazakhstan and EACPT, and has participated in major scientific events, including WCP 2023 and EACPT 2024.

Gaziza Smagulova, MD, PhD, is a Professor and Head of the Department of Pharmacology and Clinical Pharmacology at West Kazakhstan Marat Ospanov Medical University. With 30 years of combined clinical and teaching experience, she is a medical doctor and clinical pharmacologist specializing in clinical pharmacology approaches in internal diseases, pharmacogenetics, antimicrobial resistance, antimicrobial stewardship, and rational antibiotic therapy. Dr Smagulova actively participates in both intramural research projects and grant-funded studies supported by the Ministry of Science and Higher Education of Kazakhstan and the Ministry of Health, contributing to the development of targeted educational and clinical interventions. She has co-authored original research articles and review papers, including systematic reviews and meta-analyses, published in peer-reviewed international journals indexed in Scopus and Web of Science, and has an h-index of 4. A member of the Association of Clinical Pharmacologists and Pharmacists of Kazakhstan and the European Association for Clinical Pharmacology and Therapeutics (EACPT), she is committed to evidence-based practice and antibiotic stewardship. She has participated in major scientific events, including EACPT 2025, and has received institutional and ministerial recognition for her contributions.